Sensory Neurostimulation, Inc. v. Alex Azar, II

977 F.3d 969
CourtCourt of Appeals for the Ninth Circuit
DecidedOctober 16, 2020
Docket19-55036
StatusPublished
Cited by21 cases

This text of 977 F.3d 969 (Sensory Neurostimulation, Inc. v. Alex Azar, II) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sensory Neurostimulation, Inc. v. Alex Azar, II, 977 F.3d 969 (9th Cir. 2020).

Opinion

FOR PUBLICATION

UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT

SENSORY NEUROSTIMULATION, INC., No. 19-55036 a California corporation, Plaintiff-Appellant, D.C. No. 8:18-cv-00180- and CJC-JDE

FRED BURBANK, MD, CEO, President, Board Chairman, and OPINION stock holder, Plaintiff,

v.

ALEX M. AZAR II, in his official capacity as Secretary of the United States Department of Health and Human Services; U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES; CENTERS FOR MEDICARE & MEDICAID SERVICES, Defendants-Appellees,

and

SEEMA VERMA, Administrator Centers for Medicare and Medicaid Services; DEMETRIOS KOUZOUKAS, Principal Deputy Administrator Centers for Medicare and Medicaid 2 SENSORY NEUROSTIMULATION V. AZAR

Services; LAURENCE WILSON, Centers for Medicare and Medicaid Services; PETER J. GURK, MD, Medical Director, DME MAC, Jurisdiction D; ROBERT D. HOOVER, JR., MD, MPH, FACP, Medical Director, DME MAC, Jurisdiction C; STACEY V. BRENNAN, M.D., FAAFP, Medical Director, DME MAC, Jurisdiction B; WILFRED MAMUYA, MD, PHD Medical Director, DME MAC, Jurisdiction A, Defendants.

Appeal from the United States District Court for the Central District of California Cormac J. Carney, District Judge, Presiding

Argued and Submitted May 13, 2020 Pasadena, California

Filed October 16, 2020

Before: Mary M. Schroeder and Daniel P. Collins, Circuit Judges, and Michael M. Baylson, * District Judge.

Opinion by Judge Baylson

* The Honorable Michael M. Baylson, United States District Judge for the Eastern District of Pennsylvania, sitting by designation. SENSORY NEUROSTIMULATION V. AZAR 3

SUMMARY **

Medicare

The panel affirmed the district court’s dismissal for lack of jurisdiction of a lawsuit brought by a medical device supplier seeking to have Medicare “cover” the supplier’s product.

Medical devices classified as “durable medical equipment” may be eligible for Medicare reimbursement. 42 U.S.C. § 1395m(a)(2). Devices considered “personal comfort items” are categorically not covered. 42 U.S.C. § 1395y(a)(6). A nationwide determination by the Centers for Medicare and Medicaid Services (“CMS”) as to whether Medicare will reimburse beneficiaries for the purchase of the device is a “national coverage determination” (“NCD”). The Medicare statute eliminates federal question jurisdiction over lawsuits brought to “recover on any claim arising under” Medicare. 42 U.S.C. § 405(h). This “channeling requirement” forces plaintiffs to exhaust pertinent administrative channels. The channeling requirement does not apply where its application would mean no review at all.

Plaintiff-appellant Sensory NeuroStimulation, Inc. sells a prescription leg massager called “Relaxis,” and it is seeking a favorable NCD that Medicare will reimburse beneficiaries for the purchase of Relaxis. Sensory applied to CMS for an NCD, which determined that Relaxis was a personal comfort item but did not make a formal NCD.

** This summary constitutes no part of the opinion of the court. It has been prepared by court staff for the convenience of the reader. 4 SENSORY NEUROSTIMULATION V. AZAR

Sensory filed this action, and the district court granted the government’s motion to dismiss based on its finding that Medicare’s channeling requirement applied and had not been met.

The panel held that this lawsuit arose under Medicare such that the administrative channeling requirements applied. The panel also held that Sensory was not entitled to a waiver of the statute’s exhaustion requirement. The panel further held that applying the exhaustion requirement would not mean “no review at all.” Finally, the panel held that the exception to the exhaustion requirement articulated in Bowen v. Michigan Academy of Family Physicians, 476 U.S. 667 (1986), did not apply because another party – medical device suppliers – could bring the same claim through the existing administrative channel, and therefore some review was available. The panel concluded that § 405(h)’s administrative channeling requirement applied, and therefore there was no subject matter jurisdiction to hear Sensory’s claim.

COUNSEL

Linda T. Coberly (argued), Winston & Strawn LLP, Chicago, Illinois; Diana Leiden and Saul S. Rostamian, Winston & Strawn LLP, Los Angeles, California; Lauren Gailey, Winston & Strawn LLP, Washington, D.C.; for Plaintiff-Appellant.

Karen Y. Paik (argued), Assistant United States Attorney; David M. Harris, Chief, Civil Division; Nicola T. Hanna, United States Attorney; United States Attorney’s Office, Los Angeles, California; for Defendants-Appellees. SENSORY NEUROSTIMULATION V. AZAR 5

OPINION

BAYLSON, District Judge:

I. Introduction

The issue in this case is whether the district court correctly decided it lacked subject matter jurisdiction over a lawsuit brought by a medical device supplier seeking to have Medicare “cover” the supplier’s product. We conclude that the lawsuit is subject to Medicare’s administrative channeling requirements, that Plaintiff-Appellant Sensory NeuroStimulation, Inc. (“Sensory”) has not met those requirements, that there exists a way to satisfy those requirements, and that these conclusions do not completely preclude judicial review so as to trigger a key exception to the channeling requirements. We therefore affirm the district court.

II. Background

A. Statutory Background

Medicare is a half-century-old federal health insurance program for elderly and disabled Americans. Social Security Amendments of 1965, Pub. L. 89-97, 79 Stat. 286. As of 2019, it insured 61.2 million people. 2020 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds 6 (2020). These federal insureds are known generally as Medicare “beneficiaries.” The program is administered by the Centers for Medicare and Medicaid Services (“CMS”), an agency housed in the United States Department of Health and Human Services (“HHS”). Medicare administrative contractors (“MACs”) help CMS 6 SENSORY NEUROSTIMULATION V. AZAR

administer Medicare benefits in specific geographic regions. See 42 U.S.C. § 1395u.

Medicare is governed by an intricate statutory scheme, codified at 42 U.S.C. §§ 1395–1395lll. This case involves two parts of the statutory scheme: (1) provisions addressing how medical devices become covered, and (2) provisions defining the availability of judicial review.

1. Medicare’s Coverage for Medical Devices

Medicare covers a limited universe of medical devices. Relevant here, devices classified as “durable medical equipment” may be eligible for Medicare reimbursement, subject to an exception that does not apply here. 42 U.S.C. § 1395m(a)(2). Devices considered “personal comfort items,” on the other hand, are categorically not covered. Id. § 1395y(a)(6).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
977 F.3d 969, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sensory-neurostimulation-inc-v-alex-azar-ii-ca9-2020.